ARGENX SE - ADR (ARGX:NASDAQ)
$840.45 19.82 (2.4152%)
Analysed ARGENX SE - ADR (ARGX:NASDAQ) News Sources
How The argenx (ENXTBR:ARGX) Narrative Is Shifting With Vyvgart Growth And Pipeline Uncertainty
15-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
19-05-2026
yahoo.com
2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug
20-05-2026
yahoo.com
Pemphigus Vulgaris Market Analysis Report 2026-2036, Profiles of F. Hoffmann La Roche, Argenx, Sanofi, Syntimmune, Allmiral, Cabaletta Bio, and Novartis
21-05-2026
yahoo.com
Evercore ISI Raises its Price Target on argenx (ARGX)
22-05-2026
yahoo.com
argenx to Present at Upcoming Investor Conferences
27-05-2026
yahoo.com
Vyvgart Label Expansion And New CEO Put argenx Execution In Focus
27-05-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
27-05-2026
yahoo.com
argenx to Host Myositis R&D Webinar on June 23, 2026
28-05-2026
yahoo.com
Immune Thrombocytopenia Market Forecast Signals Steady Growth During the Forecast Period (2026-2036) Backed by Pipeline Advancements | DelveInsight
28-05-2026
yahoo.com
What is the current price of ARGENX SE - ADR (ARGX:NASDAQ)?
The current price of ARGENX SE - ADR (ARGX:NASDAQ) is $840.45.
ARGENX SE - ADR (ARGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARGENX SE - ADR (ARGX:NASDAQ) since the previous trading day is $19.82.
ARGENX SE - ADR (ARGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARGENX SE - ADR (ARGX:NASDAQ) since the previous trading day is 2.4152%.
What is the most recent average sentiment score for ARGENX SE - ADR (ARGX:NASDAQ)?
The most recent average sentiment score for ARGENX SE - ADR (ARGX:NASDAQ) is 62 out of 100.
What is the most recent average sentiment for ARGENX SE - ADR (ARGX:NASDAQ)?
The most recent sentiment for ARGENX SE - ADR (ARGX:NASDAQ) is .
SEC-8K** Filing Available For ARGENX SE - ADR (ARGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.